Literature DB >> 10537060

Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells.

G Schumann1, M Huell, U Machein, G Hocke, B L Fiebich.   

Abstract

Interleukin-6 (IL-6) is involved in the pathophysiology of various diseases of the CNS. Because the molecular mechanism of action of this cytokine in human neurons is not well understood, we were interested in characterizing and defining a model system for IL-6-induced activation of signal transduction cascades, transcriptional activation, and protein synthesis in human neuronal cells. We show that IL-6 leads to transcriptional activation of signal transducer and activator of transcription 3 (STAT3) in human SH-SY5Y neuroblastoma cells. IL-6-induced activation and translocation of STAT3 and to a lesser degree STAT1 but not STAT5 are demonstrated. STAT3 is phosphorylated on Tyr705 and Ser727 residues on stimulation with IL-6, suggesting maximal activation of transcription. We also show IL-6-induced phosphorylation of p42/44 mitogen-activated protein (MAP) kinase, providing evidence for MAP kinase pathway activation. The physiological relevance of our results is confirmed by IL-6-induced phosphorylation of key signaling proteins of both STAT and MAP kinase pathway in rat primary hippocampal neurons. Furthermore, de novo protein synthesis on IL-6 activation is demonstrated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537060

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

Review 1.  The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders.

Authors:  Dietrich van Calker; Knut Biber
Journal:  Neurochem Res       Date:  2005-10       Impact factor: 3.996

Review 2.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

3.  The LIM/homeodomain protein Islet1 recruits Janus tyrosine kinases and signal transducer and activator of transcription 3 and stimulates their activities.

Authors:  Aijun Hao; Veronica Novotny-Diermayr; Wei Bian; Baohong Lin; Cheh Peng Lim; Naihe Jing; Xinmin Cao
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

4.  IL-6 ameliorates defective leptin sensitivity in DIO ventromedial hypothalamic nucleus neurons.

Authors:  Louise Larsen; Christelle Le Foll; Ambrose A Dunn-Meynell; Barry E Levin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-17       Impact factor: 3.619

5.  The human PER1 gene is inducible by interleukin-6.

Authors:  Dirk Motzkus; Urs Albrecht; Erik Maronde
Journal:  J Mol Neurosci       Date:  2002 Feb-Apr       Impact factor: 3.444

6.  Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).

Authors:  Joanne P Lagmay; Wendy B London; Thomas G Gross; Amanda Termuhlen; Nicholas Sullivan; Amy Axel; Bethany Mundy; Mark Ranalli; Jason Canner; Patrick McGrady; Brett Hall
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

7.  Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function.

Authors:  Ruben V Hernandez; Alana C Puro; Jessica C Manos; Salvador Huitron-Resendiz; Kenneth C Reyes; Kevin Liu; Khanh Vo; Amanda J Roberts; Donna L Gruol
Journal:  Neuropharmacology       Date:  2015-12-17       Impact factor: 5.250

8.  Rapamycin-Sensitive Late-LTP is Enhanced in the Hippocampus of IL-6 Transgenic Mice.

Authors:  Anneke Olde Engberink; Ruben Hernandez; Pierre de Graan; Donna L Gruol
Journal:  Neuroscience       Date:  2017-11-10       Impact factor: 3.590

9.  Characterization of proteasome inhibition on astrocytes cell cycle.

Authors:  Qing-Guo Ren; Ying Yu; Xiang Luo; Xie-Min Jie; Deng-Ji Pan; Wei Wang
Journal:  J Mol Neurosci       Date:  2008-12-09       Impact factor: 3.444

10.  Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins.

Authors:  Donna L Gruol; Khanh Vo; Jennifer G Bray
Journal:  Front Cell Neurosci       Date:  2014-08-14       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.